PTH: Potential role in management of heart failureGruson, Damien;Buglioni, Alessia;Burnett, John C.(2014) Clinica Chimica Acta — Vol. 433, p. 290-296 (2014)
Filespdfdocument.pdf Restricted Access Adobe PDF447.33 KBRequest a copyDetailsAuthorsGruson, DamienUCLouvainAuthorBuglioni, AlessiaAuthorBurnett, John C.AuthorAbstractBiomarkers play an important role for the diagnosis and prognosis of heart failure (HF), a disease with high morbidity and mortality as well as a huge impact on healthcare budgets. Parathyroid hormone (PTH) is a major systemic calcium-regulating hormone and an important regulator of bone and mineral homeostasis. PTH testing is important for differential diagnosis of calcemia related disorders and for the management of patients with chronic kidney disease. As secondary hyperparathyroidism has been evidenced in HF patients, PTH testing might be relevant in HF patients for risk stratification and more personalized selection of treatment. © 2014.Show moreAffiliationsUCLouvainSSS/IREC/EDIN - Pôle d'endocrinologie, diabète et nutritionUCLouvain(SLuc) Service de biochimie médicaleShow moreCitations APA Chicago FWB Gruson, D., Buglioni, A., & Burnett, J. C. (2014). PTH: Potential role in management of heart failure. Clinica Chimica Acta, 433, 290-296. https://doi.org/10.1016/j.cca.2014.03.029 (Original work published 2014)